The Role of α6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal
Open accessAbstract
The alpha6 nicotinic acetylcholine receptor (nAChR) subunit is involved in nicotine-stimulated dopamine release in the striatum. It is expressed in brain regions and coexpressed with nAChR subtypes implicated in nicotine dependence behaviors; hence, this subunit may play a role in nicotine dependence. Using the alpha6-selective antagonist alpha-conotoxin H9A;L15A (MII[H9A;L15A]), we determined the role of alpha6* nAChRs in the pharmacological and behavioral effects of nicotine. We measured effects of pretreatment with MII[H9A;L15A] on analgesia, locomotion, and body temperature after a single injection of nicotine. Effects of MII[H9A;L15A] on nicotine reward were measured using the conditioned place preference (CPP) paradigm. We further measured physical (somatic signs and hyperalgesia) and affective [anxiety-related behavior and conditioned place aversion (CPA)] nicotine withdrawal behaviors after extended nicotine exposure. Results showed that MII[H9A;L15A] did not block acute nicotine effects on the behaviors measured. Conversely, MII[H9A:l15A] blocked the expression of nicotine CPP, as well as withdrawal-associated CPA and anxiety-related behavior in the elevated plus maze, but not withdrawal-induced somatic signs or hyperalgesia. These results suggest a role for the alpha6 nAChR subunit in nicotine reward and affective nicotine withdrawal but not acute nicotine-induced or physical withdrawal behaviors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
α6 nAChR subunits have a selective role in the affective manifestations of withdrawal and do not influence somatic withdrawal symptoms.
“There was no influence on the somatic symptoms of withdrawal, suggesting a selective role for α6 nAChR subunits in the affective manifestations of withdrawal (Jackson et al. 2009).”
From Nicotine Withdrawal (2015) · cites this paper as Jackson et al. 2009
α6* nAChRs have a documented role in withdrawal-induced conditioned place aversion.
“and there is a documented role for α6* nAChRs in withdrawal-induced CPA (Jackson et al. 2009).”
From Nicotine Withdrawal (2015) · cites this paper as Jackson et al. 2009
β2-containing and α6-containing nAChRs are necessary for conditioned place aversion, but α5 and α7 do not affect it.
“Pharmacological studies in nAChR null mice indicate that β2-containing and α6-containing nAChRs are necessary for CPA, but neither the α5, nor the α7 subunits affect CPA behavior [170, 172, 189].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [172]
Somatic signs of withdrawal are preserved in mice lacking β2 or α6 nAChR subunits.
“Interestingly, somatic signs of withdrawal are preserved in mice lacking the β2 or the α6 nAChR subunits [11, 172]”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [172]
β2 and α6 nAChR subunits are necessary for increased anxiety during withdrawal, whereas α5 and α7 may not be required.
“So far, it has been established that the β2 and α6 nAChR subunits are necessary for increased anxiety during withdrawal [170, 172], whereas, α5 and α7 may not be required [170].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [172]
Drugs that selectively inhibit α4β2* and/or α6β2* nAChRs block behaviors linked to nicotine reward and reinforcement when infused or given systemically.
“In addition, infusion and systemic administration of drugs that selectively inhibit ␣42* and/or ␣62* nAChRs blocked behaviors linked to nicotine reward and reinforcement”
From Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum (2012) · cites this paper as Jackson et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073 · see citing works
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829 · see citing works
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740 · see citing works
Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. (2004) · Science · doi:10.1126/science.1099420 · Cited by 686 · see citing works
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674 · see citing works
Molecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605 · see citing works
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 533 · see citing works
Self-citationChamptiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 505 · see citing works
Self-citationBenwell, M. E. M., & Balfour, D. J. K. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09067.x · Cited by 426 · see citing works
Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407 · see citing works
Self-citationSalminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401 · see citing works
Self-citationNicotinic effects on the firing pattern of midbrain dopamine neurons
GRENHOFF, J., ASTON‐JONES, G., & SVENSSON, T. H. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07988.x · Cited by 399 · see citing works
Le Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385 · see citing works
Champtiaux, N., Han, Z., Bessis, A., Rossi, F., Zoli, M., Marubio, L. M., McIntosh, J. M., & Changeux, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01208.2002 · Cited by 345 · see citing works
Self-citationPons, S., Fattore, L., Cossu, G., Tolu, S., Porcu, E., McIntosh, J. M., Changeux, J. P., Maskos, U., & Fratta, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3918-08.2008 · Cited by 312 · see citing works
Self-citationWada, E., McKinnon, D. H., Heinemann, S., Patrick, J., & Swanson, L. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)90248-a · Cited by 254 · see citing works
Characterization of spontaneous and precipitated nicotine withdrawal in the mouse
Damaj, M. I., Kao, W., & Martin, B. R. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054908 · Cited by 222 · see citing works
Self-citationJackson, K. J., Martin, B. R., Changeux, J. P., & Damaj, M. I. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132977 · Cited by 208 · see citing works
Self-citationWalters, C. L., Brown, S., Changeux, J.-P., Martin, B., & Damaj, M. I. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0295-x · Cited by 206 · see citing works
Self-citationNicotine dependence and reward differ between adolescent and adult male mice
Kota, D., Martin, B. R., Robinson, S. E., & Damaj, M. I. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121616 · Cited by 202 · see citing works
Self-citationHildebrand, B. E., Nomikos, G. G., Hertel, P., Schilström, B., & Svensson, T. H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01135-9 · Cited by 200 · see citing works
Drenan, R. M., Grady, S. R., Whiteaker, P., McClure-Begley, T., McKinney, S., Miwa, J. M., Bupp, S., Heintz, N., McIntosh, J. M., Bencherif, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.009 · Cited by 197 · see citing works
Self-citationAnalogs of α-Conotoxin MII Are Selective for α6-Containing Nicotinic Acetylcholine Receptors
McIntosh, J. M., Azam, L., Staheli, S. T., Dowell, C. D., Lindstrom, J. M., Kuryatov, A., Garrett, J. E., Marks, M. J., & Whiteaker, P. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.944 · Cited by 194 · see citing works
Self-citationDiversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons
Léna, C., d’Exaerde, A. D. K., Cordero‐Erausquin, M., Novère, N. G. L., Jiménez, M. D. M. A., & Changeux, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12126 · Cited by 181 · see citing works
Laviolette, S. R., & van der Kooy, D. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001197 · Cited by 180 · see citing works
Rada, P., Jensen, K., & Hoebel, B. (2001) · Psychopharmacology · doi:10.1007/s002130100781 · Cited by 141 · see citing works
Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112 · see citing works
Self-citationNovère, N. G. L., Zoli, M., Léna, C., Ferrari, R., Picciotto, M. R., Merlo‐Pich, E., & Changeux, J. (1999) · Neuroreport · doi:10.1097/00001756-199908200-00012 · Cited by 86 · see citing works
Besson, M., David, V., Suarez, S., Cormier, A., Cazala, P., Changeux, J.-P., & Granon, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0418-z · Cited by 73 · see citing works
Bruijnzeel, A. W., & Markou, A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.05.005 · Cited by 60 · see citing works
Tritto, T., McCallum, S. E., Waddle, S., Hutton, S. R., Paylor, R. E., Collins, A. C., & Marks, M. J. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200310001656966 · Cited by 57 · see citing works
Decrease of ventral tegmental area dopamine neuronal activity in nicotine withdrawal rats
Liu, Z.-H., & Jin, W.-Q. (2004) · Neuroreport · doi:10.1097/01.wnr.0000126218.25235.b6 · Cited by 41 · see citing works
Matta, S. G., McCoy, J. G., Foster, C. A., & Sharp, B. M. (2008) · Neuroendocrinology · doi:10.1159/000126860 · Cited by 35 · see citing works
Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine
Janhunen, S. K., & Ahtee, L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.015 · Cited by 32 · see citing works
Effects of nicotine and epibatidine on locomotor activity and conditioned place preference in rats
Janhunen, S. K., Linnervuo, A., Svensk, M., & Ahtee, L. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.12.012 · Cited by 24 · see citing works
Attenuation of morphine withdrawal signs by a D1 receptor agonist in the locus coeruleus of rats
Mirzaii‐Dizgah, I., Karimian, S. M., Zarrindast, M., & Sohanaki, H. (2005) · Neuroreport · doi:10.1097/01.wnr.0000180142.91644.65 · Cited by 23 · see citing works
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Changeux, J.-P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2849 · Cited by 453 · see citing works
Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction
Wittenberg, R. E., Wolfman, S. L., Biasi, M. D., & Dani, J. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108256 · Cited by 200 · see citing works
McLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 173 · see citing works
The habenulo-interpeduncular pathway in nicotine aversion and withdrawal
Antolin-Fontes, B., Ables, J. L., Görlich, A., & Ibañez-Tallon, I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.019 · Cited by 154 · see citing works
Berrendero, F., Robledo, P., Trigo, J. M., Martín-García, E., & Maldonado, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.006 · Cited by 140 · see citing works
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Papke, R. L., & Lindstrom, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108021 · Cited by 123 · see citing works
Pain, nicotine, and tobacco smoking: current state of the science
LaRowe, L. R., & Ditre, J. W. (2020) · Pain · doi:10.1097/j.pain.0000000000001874 · Cited by 122 · see citing works
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 126 · see citing works
New mechanisms and perspectives in nicotine withdrawal
Jackson, K. J., Muldoon, P. P., Biasi, M. D., & Damaj, M. I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.009 · Cited by 103 · see citing works
Self-citationThe role of the habenula in the transition from reward to misery in substance use and mood disorders
Batalla, A., Homberg, J. R., Lipina, T. V., Sescousse, G., Luijten, M., Ivanova, S. А., Schellekens, A., & LOONEN, A. J. M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.019 · Cited by 100 · see citing works
Negative affective states and cognitive impairments in nicotine dependence
Hall, F. S., Der‐Avakian, A., Gould, T. J., Markou, A., Shoaib, M. C., & Young, J. W. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.004 · Cited by 104 · see citing works
Inside-out neuropharmacology of nicotinic drugs
Henderson, B. J., & Lester, H. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.022 · Cited by 102 · see citing works
Kuryatov, A., & Lindstrom, J. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066159 · Cited by 97 · see citing works
Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 94 · see citing works
Anxiety and Depression in Bidirectional Relations Between Pain and Smoking
Zale, E. L., Maisto, S. A., & Ditre, J. W. (2015) · Behavior Modification · doi:10.1177/0145445515610744 · Cited by 92 · see citing works
Pang, X.-Y., Liu, L., Ngolab, J., Zhao-Shea, R., McIntosh, J. M., Gardner, P. D., & Tapper, A. R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.039 · Cited by 84 · see citing works
Self-citationTurner, J. R., Castellano, L. M., & Blendy, J. A. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq206 · Cited by 78 · see citing works
Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors
Henderson, B. J., Srinivasan, R., Nichols, W. A., Dilworth, C. N., Gutierrez, D. F., Mackey, E. D. W., McKinney, S., Drenan, R. M., Richards, C. I., & Lester, H. A. (2014) · Journal of General Physiology · doi:10.1085/jgp.201311102 · Cited by 78 · see citing works
Azam, L., Maskos, U., Changeux, J., Dowell, C. D., Christensen, S. B., Biasi, M. D., & McIntosh, J. M. (2010) · The FASEB Journal · doi:10.1096/fj.10-166272 · Cited by 77 · see citing works
Self-citationToll, L., Zaveri, N. T., Polgar, W. E., Jiang, F., Khroyan, T. V., Zhou, W., Xie, X., Stauber, G. B., Costello, M. R., & Leslie, F. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.322 · Cited by 78 · see citing works
Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4 subtype
Hone, A. J., Meyer, E. L., McIntyre, M., & McIntosh, J. M. (2011) · The FASEB Journal · doi:10.1096/fj.11-195883 · Cited by 76 · see citing works
Self-citationUnderstanding the habenula: A major node in circuits regulating emotion and motivation
Ables, J. L., Park, K., & Ibáñez-Tallon, I. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106734 · Cited by 76 · see citing works
Blum, K., Thompson, B., Demotrovics, Z., Femino, J., Giordano, J., Oscar-Berman, M., Teitelbaum, S., Smith, D. E., Roy, A. K., Agan, G., et al. (2015) · Journal of Reward Deficiency Syndrome · doi:10.17756/jrds.2015-008 · Cited by 73 · see citing works
Cohen, A., Treweek, J. B., Edwards, S., Leão, R. M., Schulteis, G., Koob, G. F., & George, O. (2013) · Addiction Biology · doi:10.1111/adb.12077 · Cited by 73 · see citing works
Ditre, J. W., Zale, E. L., LaRowe, L. R., Kosiba, J. D., & Vita, M. J. D. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000353 · Cited by 73 · see citing works
Sanjakdar, S. S., Maldoon, P. P., Marks, M. J., Brunzell, D. H., Maskos, U., McIntosh, J. M., Bowers, M. S., & Damaj, M. I. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.177 · Cited by 71 · see citing works
Self-citationBordia, T., Hrachova, M., Chin, M., McIntosh, J. M., & Quik, M. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194852 · Cited by 70 · see citing works
Self-citationJackson, K. J., Sanjakdar, S. S., Muldoon, P. P., McIntosh, J. M., & Damaj, M. I. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.017 · Cited by 69 · see citing works
Self-citationCohen, A., & George, O. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00041 · Cited by 67 · see citing works
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66 · see citing works
Luo, S., Zhangsun, D., Wu, Y., Zhu, X., Hu, Y., McIntyre, M., Christensen, S. B., Akcan, M., Craik, D. J., & McIntosh, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.427898 · Cited by 62 · see citing works
Self-citationAddiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61 · see citing works
Nicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models
Brunzell, D. H., Stafford, A. M., & Dixon, C. I. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0042-2 · Cited by 58 · see citing works
Self-citationNicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00013-5 · Cited by 54 · see citing works
Hone, A. J., Ruiz, M., Scadden, M., Christensen, S. B., Gajewiak, J., Azam, L., & McIntosh, J. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482059 · Cited by 53 · see citing works
Self-citationAssessing nicotine dependence using an oral nicotine free-choice paradigm in mice
Bağdaş, D., Diester, C. M., Riley, J., Carper, M., Alkhlaif, Y., Alomari, D., Alayoubi, H., Poklis, J. L., & Damaj, M. I. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107669 · Cited by 51 · see citing works
Self-citationDrenan, R. M., & Lester, H. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004671 · Cited by 51 · see citing works
Drug withdrawal-induced depression: Serotonergic and plasticity changes in animal models
Renoir, T., Pang, T. Y., & Lanfumey, L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.003 · Cited by 52 · see citing works
Powers, M. S., Broderick, H. J., Drenan, R. M., & Chester, J. A. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12042 · Cited by 49 · see citing works
Hone, A. J., Scadden, M., Gajewiak, J., Christensen, S. B., Lindstrom, J. M., & McIntosh, J. M. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080853 · Cited by 46 · see citing works
Self-citationLong-Term Nicotine Exposure Depresses Dopamine Release in Nonhuman Primate Nucleus Accumbens
Perez, X. A., Ly, J., McIntosh, J. M., & Quik, M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194084 · Cited by 43 · see citing works
Self-citationSchilaty, N. D., Hedges, D. M., Jang, E. Y., Folsom, R. J., Yorgason, J. T., McIntosh, J. M., & Steffensen, S. C. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211490 · Cited by 42 · see citing works
Self-citationBrunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 40 · see citing works
Self-citationMidde, N. M., Gomez, A. M., Harrod, S. B., & Zhu, J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.013 · Cited by 39 · see citing works
Anderson, S. M., & Brunzell, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048665 · Cited by 40 · see citing works
Self-citationPharmacogenetics of smoking cessation: role of nicotine target and metabolism genes
Gold, A. B., & Lerman, C. E. (2012) · Human Genetics · doi:10.1007/s00439-012-1143-9 · Cited by 40 · see citing works
Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors
Letchworth, S. R., & Whiteaker, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.022 · Cited by 39 · see citing works
The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice
Roni, M. A., & Rahman, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3472-y · Cited by 37 · see citing works
Xiao, C., Srinivasan, R., Drenan, R. M., Mackey, E. D. W., McIntosh, J. M., & Lester, H. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.005 · Cited by 37 · see citing works
Self-citationCahir, E., Pillidge, K., Drago, J., & Lawrence, A. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.35 · Cited by 36 · see citing works
Unraveling the neurobiology of nicotine dependence using genetically engineered mice
Stoker, A. K., & Markou, A. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.02.013 · Cited by 35 · see citing works
Nicotine regulates activity of lateral habenula neurons via presynaptic and postsynaptic mechanisms
Zuo, W., Xiao, C., Gao, M., Hopf, F. W., Krnjević, K., McIntosh, J. M., Fu, R., Wu, J., Bekker, A., & Ye, J.-H. (2016) · Scientific Reports · doi:10.1038/srep32937 · Cited by 32 · see citing works
Self-citationAssessment of nicotine withdrawal-induced changes in sucrose preference in mice
Alkhlaif, Y., Bağdaş, D., Jackson, A. B., Park, A. J., & Damaj, M. I. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.08.013 · Cited by 33 · see citing works
Self-citationSajja, R. K., & Rahman, S. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.017 · Cited by 32 · see citing works
Brunzell, D. H. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts089 · Cited by 32 · see citing works
Self-citationDivergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
Turner, J. R., Wilkinson, D. S., Poole, R. L., Gould, T. J., Carlson, G. C., & Blendy, J. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.105 · Cited by 29 · see citing works
Perez, X. A., Khroyan, T. V., McIntosh, J. M., & Quik, M. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.105 · Cited by 29 · see citing works
Self-citationCholinergic Receptors and Addiction
Papke, R. L., Brunzell, D. H., & Biasi, M. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_139 · Cited by 30 · see citing works
Self-citationAlpha6-containing nicotinic acetylcholine receptor is a highly sensitive target of alcohol
Gao, F., Chen, D., Ma, X., Sudweeks, S. N., Yorgason, J. T., Gao, M., Turner, D., Eaton, J. B., McIntosh, J. M., Lukas, R. J., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.021 · Cited by 29 · see citing works
Self-citationNative α6β4∗ nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland
Pérez‐Alvarez, A., Hernández‐Vivanco, A., McIntosh, J. M., & Albillos, A. (2011) · The FASEB Journal · doi:10.1096/fj.11-190223 · Cited by 29 · see citing works
Self-citationAttenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations
Varani, A. P., Aso, E., Moutinho, L. M., Maldonado, R. J., & Balerio, G. N. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3469-6 · Cited by 28 · see citing works
α6 nAChR subunit residues that confer α‐conotoxin BuIA selectivity
Kim, H., & McIntosh, J. M. (2012) · The FASEB Journal · doi:10.1096/fj.12-204487 · Cited by 27 · see citing works
Self-citationLiu, W., & Li, M. D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170801103009 · Cited by 27 · see citing works
Tae, H., & Adams, D. J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106747 · Cited by 26 · see citing works
Lotfipour, S., Mandelkern, M. A., Alvarez-Estrada, M., & Brody, A. L. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.20 · Cited by 26 · see citing works
Perez, X. A., McIntosh, J. M., & Quik, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12442 · Cited by 27 · see citing works
Self-citationWen, L., Yang, Z., Cui, W., & Li, M. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.103 · Cited by 26 · see citing works
Endogenous opioid system: a promising target for future smoking cessation medications
Norman, H., & D’Souza, M. S. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4582-0 · Cited by 23 · see citing works
You, S., Li, X., Xiong, J., Zhu, X., Zhangsun, D., Zhu, X., & Luo, S. (2019) · Marine Drugs · doi:10.3390/md17090490 · Cited by 22 · see citing works
Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.
LaRowe, L. R., Kosiba, J. D., Zale, E. L., & Ditre, J. W. (2018) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000218 · Cited by 21 · see citing works
Kamens, H. M., Miyamoto, J. H., Powers, M. S., Ro, K., Soto, M., Cox, R. J., Stitzel, J. A., & Ehringer, M. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.035 · Cited by 20 · see citing works
Expression of cloned α6* nicotinic acetylcholine receptors
Wang, J., Kuryatov, A., & Lindstrom, J. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.009 · Cited by 20 · see citing works
Hall, F. S., Markou, A., Levin, E. D., & Uhl, G. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06415.x · Cited by 18 · see citing works
Steffensen, S. C., Shin, S. I., Nelson, A. C., Pistorius, S. S., Williams, S. B., Woodward, T. J., Park, H.-J., Friend, L. N., Gao, M., Gao, F., et al. (2017) · Addiction Biology · doi:10.1111/adb.12559 · Cited by 18 · see citing works
Self-citationVarani, A. P., Pedrón, V. T., Moutinho, L. M., Antonelli, M. C., Bettler, B., & Balerio, G. N. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.013 · Cited by 17 · see citing works
Biała, G., Polak, P., Michalak, A., Kruk-Słomka, M., & Budzyńska, B. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.02.003 · Cited by 17 · see citing works
Zhu, J., Midde, N. M., Gomez, A. M., Sun, W., & Harrod, S. B. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00540 · Cited by 16 · see citing works
Corrie, L. W.-C., Stokes, C. A., Wilkerson, J. L., Carroll, F. I., McMahon, L. R., & Papke, R. L. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000037 · Cited by 18 · see citing works
Freitas, K., Carroll, F. I., & Negus, S. S. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000055 · Cited by 16 · see citing works
Chen, J., Brunzell, D. H., Jackson, K. J., van der Vaart, A. D., Ma, J. Z., Payne, T. J., Sherva, R., Farrer, L. A., Gejman, P. V., Levinson, D. F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028790 · Cited by 15 · see citing works
Self-citationJackson, K. J., & Damaj, M. I. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.12.005 · Cited by 15 · see citing works
Self-citationMolecular, Neuronal, and Behavioral Effects of Ethanol and Nicotine Interactions
Klenowski, P. M., & Tapper, A. R. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2017_89 · Cited by 15 · see citing works
Genetic matters: Thirty years of progress using mouse models in nicotinic research
Marks, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.021 · Cited by 13 · see citing works
A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior
Soll, L. G., Grady, S. R., Salminen, O., Marks, M. J., & Tapper, A. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.001 · Cited by 14 · see citing works
Guildford, M. J., Sacino, A. V., & Tapper, A. R. (2016) · Alcohol · doi:10.1016/j.alcohol.2016.08.006 · Cited by 14 · see citing works
Li, W., Han, H., Liu, Q., Su, K., Yang, Z., Cui, W., Yuan, W., Ma, Y., Fan, R., Chen, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09492-8 · Cited by 14 · see citing works
Nega, S., Marquez, P. V., Hamid, A., Ahmad, S. M., & Lutfy, K. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24649 · Cited by 14 · see citing works
Brain Nicotinic Receptors as Emerging Targets for Drug Addiction
Rahman, S. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00008-9 · Cited by 13 · see citing works
Neuroscience of nicotine for addiction medicine
D’Souza, M. S. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.008 · Cited by 13 · see citing works
Deletion of lynx1 reduces the function of α6* nicotinic receptors
Parker, R. L., O’Neill, H. C., Henley, B. M., Wageman, C. R., Drenan, R. M., Marks, M. J., Miwa, J. M., Grady, S. R., & Lester, H. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188715 · Cited by 14 · see citing works
Lee, B. G., Anastasía, A., Hempstead, B. L., Lee, F. S., & Blendy, J. A. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv047 · Cited by 13 · see citing works
Li, X., You, S., Xiong, J., Qiao, Y., Yu, J., Zhangsun, D., & Luo, S. (2020) · Marine Drugs · doi:10.3390/md18120646 · Cited by 12 · see citing works
Monkey Adrenal Chromaffin Cells Express α6β4* Nicotinic Acetylcholine Receptors
Hernández‐Vivanco, A., Hone, A. J., Scadden, M., Carmona‐Hidalgo, B., McIntosh, J. M., & Albillos, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094142 · Cited by 12 · see citing works
Self-citationCardenas, A. M., Bai, Y., Heydary, Y. H., Li, J., Leslie, F. M., & Lotfipour, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063145 · Cited by 10 · see citing works
Collo, G., Cavalleri, L., Zoli, M., Maskos, U., Ratti, E., & Pich, E. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00572 · Cited by 10 · see citing works
More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder
Moerke, M. J., McMahon, L. R., & Wilkerson, J. L. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018028 · Cited by 11 · see citing works
Carroll, F. I., Navarro, H. A., Mascarella, S. W., Castro, A. H., Luetje, C. W., Wageman, C. R., Marks, M. J., Jackson, A. B., & Damaj, M. I. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00077 · Cited by 10 · see citing works
Self-citationConditioned Place Preference as a Preclinical Model for Screening Pharmacotherapies for Drug Abuse
Bardo, M. T., Horton, D. B., & Yates, J. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420172-9.00007-2 · Cited by 9 · see citing works
Bağdaş, D., AlSharari, S. D., Roni, M. A., Campbell, V. C., Muldoon, P. P., Carroll, F. I., & Damaj, M. I. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.027 · Cited by 9 · see citing works
Self-citationTC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors
Wall, T. R., Henderson, B. J., Voren, G., Wageman, C. R., Deshpande, P., Cohen, B. N., Grady, S. R., Marks, M. J., Yohannes, D., Kenny, P. J., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00641 · Cited by 8 · see citing works
- Authors
- Jackson, K. J., McIntosh, J. M., Brunzell, D. H., Sanjakdar, S. S., & Damaj, M. I.
- Affiliations
- Virginia Commonwealth University (US)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 331
- Issue
- 2
- Pages
- 547-554
- ISSN
- 0022-3565 (ISSN-L)
- PMC
- PMC2775251
- OpenAlex
- W2133971381
- Cited by
- 135
- References
- 38
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 3 · 2021: 2 · 2020: 8 · 2019: 7 · 2018: 6 · 2017: 8 · 2016: 8 · 2015: 15 · 2014: 17 · 2013: 13 · 2012: 14
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (MH53631, GM 48677)
- National Institute of Mental Health (MH53631, R01MH053631, R29MH053631)
- National Institute on Drug Abuse (R01DA012610, DA 05274, DA-12610, R03DA023114, DA023114, P50DA005274)
- National Institute of General Medical Sciences (P01GM048677, GM48677)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotine reward, nicotine withdrawal, conditioned place preference, conditioned place aversion, anxiety-like behavior, nicotine dependence, dopamine release, striatum, hyperalgesia, locomotion, analgesia, body temperature
- MeSH terms
- Animals, Anxiety, Avoidance Learning, Body Temperature, Calcium Channel Blockers, Conditioning, Operant, Dose-Response Relationship, Drug, Injections, Intraventricular, Male, Mice, Inbred C57BL, Motor Activity, Nicotine, Pain Measurement, Reaction Time, Receptors, Nicotinic, Reward, Substance Withdrawal Syndrome, Nicotinic Agonists, Nicotinic Antagonists, Conotoxins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review